Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 10, 2026 · Other material event · Financial statements
InMed Pharmaceuticals Inc.
10
Other material event
Jun 10, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Other material event · Financial statements |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | InMed Pharmaceuticals Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. 1 NASDAQ: INM Suite 1445-885 West Georgia St. com InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements Vancouver, BC - June 4, 2026 - InMed Pharmaceuticals Inc. |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 3, 2026 |
| Accession number | 0001062993-26-003132 |
| Reported items | Other events the company considers material, Financial statements and exhibits See Analysis tab for workforce implications |
